BASF and Catalent Team up to Solve Bioavailability Challenges

BASF says it has entered into a broad collaboration and open alliance with Catalent Pharma Solutions (Somerset, NJ), to provide solutions to overcome bioavailability challenges of new molecular entities with solubility or permeability challenges. The companies aim to combine their expertise to provide pharmaceutical customers with a range of solutions to address pipeline challenges with a large majority of BCS Class II and IV poorly bioavailable compounds. BASF has ingredient formulation and material science expertise, as well as excipient products and has been a...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers